VKORC1 and CYP2C9 Genetic Variant-Associated Warfarin Treatment Outcomes and Artificial Intelligence-Based Dosing Optimization Among Chinese Patients

Fangli Liu, Dongyun Nan, Shaoke Li, Yi Wang, Yiqun Cai, Bo Liu, Jialing Peng, Jinyun Ye, Zilong Pang, Jiexin Deng

Open source

DOI: 10.31083/pharmazie58987
Published: 2026-10-23
Container: Die Pharmazie
Publisher: IMR Press
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.31083/pharmazie58987,
  title = {VKORC1 and CYP2C9 Genetic Variant-Associated Warfarin Treatment Outcomes and Artificial Intelligence-Based Dosing Optimization Among Chinese Patients},
  author = {Fangli Liu and Dongyun Nan and Shaoke Li and Yi Wang and Yiqun Cai and Bo Liu and Jialing Peng and Jinyun Ye and Zilong Pang and Jiexin Deng},
  year = {2026},
  journal = {Die Pharmazie},
  doi = {10.31083/pharmazie58987},
  url = {https://doi.org/10.31083/pharmazie58987}
}

RIS

TY  - JOUR
TI  - VKORC1 and CYP2C9 Genetic Variant-Associated Warfarin Treatment Outcomes and Artificial Intelligence-Based Dosing Optimization Among Chinese Patients
AU  - Fangli Liu
AU  - Dongyun Nan
AU  - Shaoke Li
AU  - Yi Wang
AU  - Yiqun Cai
AU  - Bo Liu
AU  - Jialing Peng
AU  - Jinyun Ye
AU  - Zilong Pang
AU  - Jiexin Deng
PY  - 2026
JO  - Die Pharmazie
DO  - 10.31083/pharmazie58987
UR  - https://doi.org/10.31083/pharmazie58987
ER  -

APA

Liu, F., Nan, D., Li, S., Wang, Y., Cai, Y., Liu, B., Peng, J., Ye, J., Pang, Z., & Deng, J. (2026). VKORC1 and CYP2C9 Genetic Variant-Associated Warfarin Treatment Outcomes and Artificial Intelligence-Based Dosing Optimization Among Chinese Patients. Die Pharmazie. https://doi.org/10.31083/pharmazie58987

Source records

crossref · retrieved 2026-11-06T02:33:17.009Z